Prevention of experimental autoimmune myasthenia gravis by rat Crry-Ig: A model agent for long-term complement inhibition in vivo.

Authors:
Hepburn NJ; Chamberlain-Banoub JL; Williams AS; Morgan BP; Harris CL.

Journal:
Mol Immunol

Publication Year: 2007

DOI:
10.1016/j.molimm.2007.06.144

PMCID:
PMC2572221

PMID:
17651804

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Mol Immunol

Abbreviation: Mol Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2.
Purbey PK; Roy K; Gupta S and 1 more (2023) - Transparency Score: 1/6
Humoral response to the BBIBP-CorV vaccine over time in healthcare workers with or without exposure…
Badano MN; Sabbione F; Keitelman I and 12 more (2022) - Transparency Score: 3/6
Identification of virus-specific B-cell epitopes by convalescent plasma from COVID-19 patients.
Wang L; Zhao J; Schank M and 13 more (2022) - Transparency Score: 4/6
Influence of SARS-CoV-2 inactivation by different chemical reagents on the humoral response evaluat…
de Castro Barbosa E; de Souza Andrade A; Duarte MM and 7 more (2022) - Transparency Score: 3/6
Synergism of TNF-α and IFN-β triggers human airway epithelial cells death by apoptosis and pyroptos…
Sun R; Jiang K; Zeng C and 4 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"We thank Dr. Jim Neale for scoring the cellular infiltration and Nicholas Amos for invaluable advice on half-life analysis. This work was funded by the Welsh Office of Research and Development (WORD; DTA01/1/014) and the Wellcome Trust (068823)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025